Kronos Bio, Inc. financial data

Symbol
KRON on Nasdaq
Industry
Pharmaceutical Preparations
Location
1300 S. El Camino Real, Suite 400, San Mateo, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 823 % -31.1%
Debt-to-equity 32 % +54.8%
Return On Equity -68.7 % -43.5%
Return On Assets -52 % -31.2%
Operating Margin -1.65 K % +84.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 60.1 M shares +4.28%
Common Stock, Shares, Outstanding 60.1 M shares +4.77%
Entity Public Float 48.3 M USD -76.4%
Common Stock, Value, Issued 60 K USD +5.26%
Weighted Average Number of Shares Outstanding, Basic 59.5 M shares +4.15%
Weighted Average Number of Shares Outstanding, Diluted 59.5 M shares +4.15%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 7.59 M USD +521%
Research and Development Expense 80.9 M USD -8.99%
General and Administrative Expense 39.2 M USD -5.64%
Operating Income (Loss) -125 M USD +3.03%
Nonoperating Income (Expense) 8.94 M USD +47.4%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -116 M USD +5.51%
Earnings Per Share, Basic -1.99 USD/shares +8.72%
Earnings Per Share, Diluted -1.99 USD/shares +8.72%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 46.2 M USD -25.1%
Cash, Cash Equivalents, and Short-term Investments 248 M USD -27%
Assets, Current 158 M USD -31.8%
Property, Plant and Equipment, Net 8.12 M USD -35.2%
Operating Lease, Right-of-Use Asset 13.9 M USD -42.4%
Other Assets, Noncurrent 577 K USD -50.6%
Assets 183 M USD -36.7%
Accounts Payable, Current 2.23 M USD -63.1%
Employee-related Liabilities, Current 1 M USD -19.1%
Accrued Liabilities, Current 4.99 M USD -24.4%
Contract with Customer, Liability, Current 8.67 M USD +0.17%
Liabilities, Current 19 M USD -24.7%
Contract with Customer, Liability, Noncurrent 2.52 M USD -75.1%
Operating Lease, Liability, Noncurrent 24.5 M USD -12.5%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 46 M USD -27.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -49 K USD +86.4%
Retained Earnings (Accumulated Deficit) -539 M USD -27.6%
Stockholders' Equity Attributable to Parent 137 M USD -39.3%
Liabilities and Equity 183 M USD -36.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -23.9 M USD -302%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities 5.77 M USD
Common Stock, Shares Authorized 200 M shares 0%
Common Stock, Shares, Issued 60.1 M shares +4.77%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -18.1 M USD -47.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 48.2 M USD -26.6%
Deferred Tax Assets, Valuation Allowance 123 M USD +22.2%
Deferred Tax Assets, Gross 127 M USD +18%
Operating Lease, Liability 27.5 M USD -11.3%
Depreciation 475 K USD -16.5%
Payments to Acquire Property, Plant, and Equipment 7 K USD -94.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -116 M USD +5.91%
Lessee, Operating Lease, Liability, to be Paid 36.5 M USD -3.99%
Property, Plant and Equipment, Gross 15.9 M USD -14.7%
Operating Lease, Liability, Current 3.02 M USD -0.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.41 M USD +307%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.92 M USD +2.99%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9 M USD +28.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.87 M USD -9.82%
Deferred Tax Assets, Operating Loss Carryforwards 68.3 M USD +16.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 4.37 M USD +43.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.02 M USD
Operating Lease, Payments 6.1 M USD +8.93%
Additional Paid in Capital 676 M USD +4.23%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 2.28 M USD +4.02%
Deferred Tax Assets, Net of Valuation Allowance 3.56 M USD -46.1%
Share-based Payment Arrangement, Expense 26.1 M USD -13%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%